Skip to main content
SpringerLink
Log in

Macronutrient Intake and Estrogen Metabolism in Healthy Postmenopausal Women

  • Conference Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The purpose of this study was to determine if dietary factors could bias estimates of the relationships between estrogen metabolites and breast cancer risk factors. A lower ratio of urinary 2-hydroxyestrone/16α-hydroxyestrone (2/16) has been associated with breast cancer diagnosis. However, both estrogen metabolism and breast cancer risk have been associated with dietary intake, and breast cancer patients may have different dietary patterns than healthy controls. An association between urinary 2/16 levels and breast cancer risk may be due to transitory dietary change after diagnosis, or due to other breast cancer risk factors which have been associated to steroid hormone metabolism. Thirty- seven healthy postmenopausal women provided two 24-h urine samples at a two-week interval. Six 24-h diet recalls were administered in this same time period. In linear regression analysis, dietary fat-to-fiber ratio (fat/fiber) and the saturated fat/soluble fiber ratio was inversely associated with urinary 2/16 values (b=−0.22, 95% CI (−0.43, −0.01; b=−0.26, 95% CI (−0.43, −0.09), respectively). The effects of these dietary factors on 2/16 were independent of body mass index or other breast cancer risk factors. These study results suggest that some of the variation in estrogen metabolite levels among postmenopausal Caucasian women may be due to dietary intake, and that dietary factors should be carefully measured and evaluated when investigating the relationship between estrogen metabolites and breast cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bradlow HL, Telang NT, Sepkov DW, Osborne MP: 2-hydroxyestrone: the ‘good’ estrogen. J Endocrin 150: S256-S265, 1996

    Google Scholar 

  2. Schneider J, Huh MM, Bradlow HL, Fishman J: Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 259: 4840-4845, 1984

    Google Scholar 

  3. Telang NT, Suto A, Wong GY, Bradlow HL: Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst. 84: 634-638, 1992

    Google Scholar 

  4. Zhu BT, Liehr JG: Inhibition of the catechol-O-methyltransferase catalyzed O-methylation of 2-and 4-hydroxyestradiol by catecholamines: Implications for the mechanism of estrogen-induced carcinogenesis. Arch Biochem Biophysic 304: 248-256, 1993

    Google Scholar 

  5. Osborne MP, Karmali RA, Hershcopf RJ, Bradlow HL, Kourides IA, Williams WR, Rosen PP, Fishman J: Omega-3 fatty acids: Modulation of estrogen metabolism and potential for breast cancer prevention. Cancer Inv 6: 629-631, 1988

    Google Scholar 

  6. Kabat GC, Chang CJ, Sparano JA, Sepkovic DW, Hu XP, Khalil A, Rosenblatt R, Bradlow HL: Urinary estrogen metabolites and breast cancer: A case-control study. Cancer Epidem Biomark Prev. 6: 505-509, 1997

    Google Scholar 

  7. Schneider J, Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, Fishman J: Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci USA 79: 3047-3051, 1982

    Google Scholar 

  8. Ho GH, Luo XW, Ji CY, Foo SC, Ng EH: Urinary 2/16-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomakrer of breast cancer. Ann Aca Med Singapore 27: 294-299, 1998

    Google Scholar 

  9. Coker AL, Crane MM, Sticca RP, Sepkovic DW: Re: Ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst 89: 89, 1997

    Google Scholar 

  10. Zheng W, Dunning L, Jin F, Holtzman J: Correspondence re: G.C. Kabat et al., Urinary estrogen metabolites and breast cancer: A case-control study. Cancer Epidem Biomark Prev 7: 85-86, 1998

    Google Scholar 

  11. Meilahn E, DeStavola B, Allen D, Fentim I, Bradlow H, Sepkovic D, Kuller L: Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br J Cancer 78: 1250-1255, 1998

    Google Scholar 

  12. Ursin G, London S, Stanczyk FZ, Gentzchein E, Paganini-Hill A, Ross RK, Pike MC: Urinary 2-hydroxyestrone/16a-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 91: 1067-1072, 1999

    Google Scholar 

  13. Longcope C, Gorbach S, Goldin B, Woods M, Dwyer J, Morrill A, Warram J: The effect of a low fat diet on estrogen metabolism. J Clin Endo Met 64: 1246-1250, 1987

    Google Scholar 

  14. Anderson KE, Kappas A, Conney AH, Bradlow HL, Fishman J: The influence of dietary protein and carbohydrate on the principal oxidative biotransformations of estradiol in normal subjects. J Clin Endo Met. 59: 103-107, 1984

    Google Scholar 

  15. Musey PI, Collins DC, Bradlow HL, Gould KG, Preedy JRK: Effect of diet on oxidation of 17b-estradiol in vivo. J Clin Endo Met. 65: 792-795, 1987

    Google Scholar 

  16. Prentice RL: Dietary fat reduction as a hypothesis for the prevention of postmenopausal breast cancer, and a discussion of hypothesis testing research strategies. In: Weisburger EK (ed.) Diet and Breast Cancer, Vol. 364, Plenum Press, New York, 1994 pp. 25-33

    Google Scholar 

  17. Wynder EL, Cohen LA, Muscat JE, Winters B, Dwyer JT, Blackburn G: Breast Cancer: weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst 89: 766-775, 1997

    Google Scholar 

  18. Bradlow HL, Hershcopf R, Martucci C, Fishman J: 16-alphahydroxylation of estradiol: a possible risk marker for breast cancer. Ann NY Acad Sci 464: 138-151, 1986

    Google Scholar 

  19. Schneider J, Bradlow HL, Strain G, Levin J, Anderson K, Fishman J: Effects of obesity on estradiol metabolism: decreased formation of nonuterotropic metabolites. J Clin Endo Met 56: 973-978, 1983

    Google Scholar 

  20. Bradlow HL, Sepkovic DW, Klug T, Osborne MP: Application of an improved ELISA assay to the analysis of urinary estrogen metabolites. Steroids 63: 406-413, 1998

    Google Scholar 

  21. Feskanich D, Sielaff B, Chong K, Buzzard I: Computerized collection and analysis of dietary intake information. Comput Meth Prog Bio 30: 47-57, 1989

    Google Scholar 

  22. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, and Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879-1886, 1989

    Google Scholar 

  23. Benichou J: A computer program for estimating individualized probabilities of breast cancer. Comp Biomed Res 26: 373-382, 1993

    Google Scholar 

  24. Tran ZV, Weltman A: Generalized equation for predicting body density of women from girth measurements. Med Sci Sport Exer 21: 101-104, 1989

    Google Scholar 

  25. Lohman T: Applicability of body composition technqiues and constants for children and youth. In: Pandolf K (ed.) Exercise and Sports Science Reviews. Macmillan, New York, 1986, pp. 325-357

    Google Scholar 

  26. Littell RC, Millikin GA, Stroup WW, Wolfinger RD: SAS system for mixed models, SAS Institute Inc., Cary 1996, p. 633

    Google Scholar 

  27. Falk RT, Rossi SC, Fears TR, Sepkovic DW, Migella A, Adlercreutz H, Donaldson J, Bradlow HL, Zeigler RG: A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid. Cancer Epidem Biomark Prev 9: 81-87, 2000

    Google Scholar 

  28. Michaud DS, Manson JE, Spiegelman D, Barbieri RL, Sepkovic DW, Bradlow HL, Hankinson SE: Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidem Biomark Prev 8: 1059-1064, 1999

    Google Scholar 

  29. Chen Z, Zheng W, Dunning L, Anderson K, Parrish R, Holzman JL: Within-person variability of the ratios of urinary 2-hydroxyestrone to 16alpha hydroxyestrone in Caucasion women. Steroids 64: 856-859, 1999

    Google Scholar 

  30. Greenwald P: Role of dietary fat in the causation of breast cancer: Point, Cancer Epidem Biomark Prev 8: 3-7, 1999

    Google Scholar 

  31. Gerber M: Fibre and breast cancer. Eur J Cancer Prev 7: S63-S67, 1998

    Google Scholar 

  32. Dorgan JF, Judd JT, Longcope C, Brown C, Schatzkin A, Clevidence BA, Campbell WS, Nair PP, Franz C, Kahle L, Taylor PR: Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. Am J Clin Nutr 64: 850-855, 1996

    Google Scholar 

  33. Walter-Sack I, Klotz U: Influence of diet and nutritional status on drug metabolism. Clin Pharmacokinetics Jul 31: 47-64, 1996

    Google Scholar 

  34. Adlercreutz H: Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scan J Clin Lab Invest 201: 3-23, 1990

    Google Scholar 

  35. Armstrong BK, Brown JB, Clarke HT, Cooke DK, Hahnel R, Masarei JR, Ratajczak T: Diet and reproductive hormones: a study of vegetarian and nonvegetarian postmenopausal women. J Natl Cancer Inst 67: 761-767, 1981

    Google Scholar 

  36. Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, Swenson L, Woods MN: Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. NEJM 307: 1542-1547, 1982

    Google Scholar 

  37. Gorbach SL: Estrogens, breast cancer, and intestinal flora. Rev Infect Dis 6: S85-S90, 1984

    Google Scholar 

  38. Goldin BR, Gorbach SL: Effect of diet on the plasma levels, metabolism, and excretion of estrogens. Am J Clin Nutr 48: 787-790, 1988

    Google Scholar 

  39. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hamalainen E: Estrogen metabolism and excretion in Oriental and Caucasion women. J Natl Cancer Inst 86: 1076-1082, 1994

    Google Scholar 

  40. Katsouyanni K, Boyle P, Trichopoulos D: Diet and urine estrogens among postmenopausal women. Oncology 48: 490-494, 1991

    Google Scholar 

  41. Adlercreutz H, Fotsis T, Hockerstedt K, Hamalainen E, Bannwart C, Bloigu S, Valtonen A, Ollus A: Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J Ster Biochem 34: 527-530, 1989

    Google Scholar 

  42. Adlercreutz H, Fotis T, Bannwart C, Hamalainen E, Bloigu S, Ollus A: Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. J Ster Biochem 24: 289-296, 1986

    Google Scholar 

  43. Liehr JG, Ricci MJ: 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93: 3294-3296, 1996

    Google Scholar 

  44. Cohen LA, Zhao Z, Zang EA, Wynn TT, Simi B, Rivenson A: Wheat bran and psyllium diets: effects on Nmethylnitrosourea-induced mammary tumorigenesis in F344 rats. J Natl Cancer Inst 88: 899-907, 1996

    Google Scholar 

  45. Bradlow HL, Michnovicz JJ, Halper M, Miller DG, Wong GYC, Osborne M: Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidem Biomark Prev 3: 591-595, 1994

    Google Scholar 

  46. Adlercreutz H: Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Persp 103: 103-112, 1995

    Google Scholar 

  47. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hamalainen E: Response: Estrogen metabolism and excretion in Oriental and Caucasion women. J Natl Cancer Inst 86: 1644-1645, 1994

    Google Scholar 

  48. Westerlind KC, Gibson KJ, Wolfe P: The effect of diurnal and menstrual cyclicity and menopausal status on estrogen metabolites: implications for disease-risk assessment. Steroids 64: 233-243, 1999

    Google Scholar 

  49. Pasagian-Macaulay A, Meilahn EN, Bradlow HL, Sepkovic DW, Buhari AM, Simkin-Silverman L, Wing RR, and Kuller LH: Urinary markers of estrogen metabolism 2-and 16 alpha-hydroxylation in premenopausal women. Steroids 61: 461-467, 1996

    Google Scholar 

  50. Fishman J, Boyer R, Hellman L: Influence of body weight on estradiol metabolism in young women. J Clin Endo Met 41: 989-991, 1975

    Google Scholar 

  51. Taioli E, Bradlow HL, Garbers SV, Sepkovic DW, Osborne MP, Trachman J, Ganguly S, Garte SJ: Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk. Cancer Det Prev 23: 232-237, 1999

    Google Scholar 

  52. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FC: Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122: 51-65, 1985

    Google Scholar 

  53. Hebert JR, Augustine A, Barone J, Kabat GC, Kinne DW, Wynder EL: Weight, height, and body mass index in the prognosis of breast cancer: early results of a prospective study. Int J Can 42: 315-318, 1988

    Google Scholar 

  54. Hebert JR, Hurley TG, Ma Y: The effect of dietary exposures on recurrence and mortality in early stage breast cancer. Breast Cancer Res Treat 51: 17-28, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, University of South Carolina, School of Public Health, Columbia, SC, USA

    Jay H. Fowke & James R. Hebert

  2. Division of Population Studies, South Carolina Cancer Center, Columbia, SC, USA

    Jay H. Fowke & James R. Hebert

  3. Department of Obstetrics and Gynecology, University of Massachusetts Medical School, Worcester, MA, USA

    Christopher Longcope

Authors
  1. Jay H. Fowke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher Longcope
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James R. Hebert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fowke, J.H., Longcope, C. & Hebert, J.R. Macronutrient Intake and Estrogen Metabolism in Healthy Postmenopausal Women. Breast Cancer Res Treat 65, 1–10 (2001). https://doi.org/10.1023/A:1006429920719

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006429920719

Search

Navigation